← Back to Search

Amino Acid

Protein Intake for Cancer Patients

N/A

Recruiting

Led By Carla Prado, PhD

Research Sponsored by University of Alberta

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Outpatients age 45-80 years

Patients attending the new patient clinic at the Cross Cancer Institute with a diagnosis of colorectal cancer or breast cancer (stages II to III)

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 8.5 hours

Awards & highlights

Study Summary

This trial is testing how much protein cancer patients need to sustain muscle mass and overall health. A novel, non-invasive approach is being used to determine protein needs. The results will inform nutritional recommendations and guidelines with the goal of improving outcomes for people with cancer.

Who is the study for?

This trial is for outpatients aged 45-80 with stage II to III colorectal or breast cancer, who can visit the clinic within 4 weeks of starting chemo or after surgery if no chemo. They must be able to walk and provide samples. Excluded are those with kidney issues, abnormal glucose metabolism, severe allergies, premenopausal women, recent hormone/immunotherapy recipients, certain comorbidities or substance dependencies.Check my eligibility

What is being tested?

The study aims to determine protein needs in patients with colorectal or breast cancer using a new non-invasive method. This could lead to better nutritional guidelines and improve patient outcomes by maintaining muscle mass and overall health during treatment.See study design

What are the potential side effects?

Since this trial focuses on assessing dietary protein needs rather than testing a drug intervention, there may not be direct side effects like those associated with medications; however, participants might experience discomfort from providing urine, breath and blood samples.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am between 45 and 80 years old.

Select...

I have stage II or III colorectal or breast cancer and am a new patient at the Cross Cancer Institute.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 8.5 hours

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~8.5 hours

This trial's timeline: 3 weeks for screening, Varies for treatment, and 8.5 hours for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

13C Phenylalanine Oxidation

Trial Design

1Treatment groups

Experimental Treatment

Group I: Phenylalanine intakeExperimental Treatment1 Intervention

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Phenylalanine intake

2016

N/A

~50

0 / 2Eligibility criteria met

Find a Location

Who is running the clinical trial?

University of AlbertaLead Sponsor

889 Previous Clinical Trials

385,108 Total Patients Enrolled

Carla Prado, PhDPrincipal InvestigatorUniversity of Alberta

8 Previous Clinical Trials

591 Total Patients Enrolled

Carla Prado, PhD, RDPrincipal InvestigatorUniversity of Alberta

Media Library

Phenylalanine (Amino Acid) Clinical Trial Eligibility Overview. Trial Name: NCT04144907 — N/A

Colorectal Cancer Research Study Groups: Phenylalanine intake

Colorectal Cancer Clinical Trial 2023: Phenylalanine Highlights & Side Effects. Trial Name: NCT04144907 — N/A

Phenylalanine (Amino Acid) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04144907 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any vacancies for participants in this trial?

"Affirmative. According to the clinicaltrials.gov site, this research study is currently looking for volunteers to take part in it; its initial posting was on 4/26/2021 and last update occurred 10/3/2022. The trial requires 30 participants at one medical centre."

Answered by AI

Who qualifies as a prospective participant in this research program?

"This trial is searching for 30 individuals suffering from breast cancer, aged between 45 and 80. To be eligible to join, patients must meet the following prerequisites: they should be outpatients within that age range, attending a specific clinic with either colorectal or breast cancer (of stages II-III), capable of participating in baseline visits 4 weeks after starting chemotherapy or at least 4 weeks post surgery if not receiving said treatment; and ambulatory."

Answered by AI

Is the eligibility age for this medical experiment limited to those over 20 years old?

"The ideal candidates for this clinical trial have attained the age of 45 but are yet to reach their 80th year."

Answered by AI

How many individuals have agreed to participate in this trial?

"Confirmed. According to clinicaltrials.gov, the research was posted on April 26th 2021 and is currently recruiting participants. 30 volunteers are needed at a single medical site for this trial."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Protein Needs Study

Carla Prado 2021. "Protein Needs Study". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04144907.